T-Rosette-Forming Cells, Cellular Immunity and Cancer
- 27 February 1975
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 292 (9) , 475-476
- https://doi.org/10.1056/nejm197502272920910
Abstract
Development of accurate methods for enumeration of T and B lymphocytes in human peripheral blood during the past three years1 has led to a plethora of papers on T and B cells in various pathologic states. Just as B cells can be subdivided on the basis of surface immunoglobulins into various subpopulations, T-cell subpopulations with differing biologic properties almost certainly exist,2 perhaps some responsible for production of one or more mediators of cellular immunity, another for homograft rejection, a third for DNA synthesis in response to antigen or mitogen, and still another for cytotoxicity against tumor cells. The most widely . . .Keywords
This publication has 5 references indexed in Scilit:
- Unmasking by antimetabolites of receptors for sheep red blood cells on human lymphocytesCellular Immunology, 1974
- Immunopathologic changes in patients with cutaneous malignant melanoma following intratumoral inoculation of BCG: Correlation with cell-mediated immunityInternational Journal of Cancer, 1974
- The Therapeutic Uses of Transfer FactorHospital Practice, 1974
- Thymus-Derived Rosette-Forming CellsNew England Journal of Medicine, 1973
- Thymus-Derived Rosette-Forming Cells in Various Human Disease States: Cancer, Lymphoma, Bacterial and Viral Infections, and Other DiseasesJournal of Clinical Investigation, 1973